Tepezza Infusions linked to Hearing Loss

Tepezza Infusions linked to Hearing Loss

#6

Hair Loss

  • 4.5

Clinical trials of Tepezza, a medication for the treatment of thyroid eye disease, has been linked to hearing loss. If you received infusions of Tepezza and subsequently developed hearing loss or other auditory disorders, you may be eligible for compensation. 

Qualification Criteria

  • Received infusions of Tepezza as part of a clinical trial. 

  • Subsequently developed hearing conditions including (but not limited to):

    • Hearing loss

    • Deafness

    • Hypoacusis

    • Muffled hearing

    • Tinnitus

    • Ringing of the ears

    • Autophony

    • Ear plugging sensation

    • Eustachian tube dysfunction

Total Settlement Amount

Undefined. Defendant company has a market cap of $25 billion.

Type of Compensation

Monetary compensation to reimburse medical expenses, plus punitive damages for pain and suffering.

Detailed description

Tepezza was an experimental drug developed by Horizon Pharmaceuticals for the treatment of thyroid eye disease. Participants in clinical trials received the medication by infusion.

Tepezza has subsequently been linked to numerous instances of hearing loss and other auditory problems, including:

  • Hearing loss

  • Deafness

  • Hypoacusis

  • Muffled hearing

  • Tinnitus

  • Ringing of the ears

  • Autophony

  • Ear plugging sensation

  • Eustachian tube dysfunction

Plaintiffs allege that Horizon Pharmaceuticals failed to adequately warn participants of the risks involved. 

If you received Tepezza infusions and have subsequently developed hearing loss or other auditory conditions, you may be eligible for six-figure compensation. Fill out the form below to see if you qualify.

Free Case Review

See also: